CRC Opportunity Strong position in colorectal cancer screening and education about FIT testing opportunities for clinics and national programs. Leverage SENTiFIT 800 Analyzer and FIT line launches to target hospitals, public health systems, and screening programs seeking automated, scalable solutions.

Global Partnerships Established collaborations with key diagnostic players and academic partners indicate receptiveness to integration and co-development. Use partnerships to pitch bundled solutions, co-marketing, and cross-sell of reagents, analyzers, and assay development for expanding markets.

Emerging Markets Recent participation in international events and Dubai-based presence signals growth beyond Italy. Target expansion in the Middle East, Europe, and other regions through turnkey screening portfolios, service support, and local regulatory-ready reagent kits.

Integrated Platform Portfolio spans Clinical Chemistry, Immunochemistry and Molecular Biology reagents with automation-friendly offerings. Present comprehensive install-base upgrades, compatibility assessments, and migration paths to customers seeking end-to-end diagnostic workflows.

Growing Footprint Revenue in the low-to-mid single-digit millions with a path toward scale through expanded product lines and global support. Position as a nimble partner for middle-market labs and regional distributors needing flexible pricing, training, and after-sales service.